(Q34303364)

1 August 2017

1 reference

title

Cholesterol risk management: a systematic examination of the gap from evidence to practice (English)

1 reference

1 August 2017

Olson KL

1

1 reference

1 August 2017

Bungard TJ

series ordinal

2

1 reference

1 August 2017

Tsuyuki RT

series ordinal

3

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

21

1 reference

1 August 2017

issue

7

1 reference

1 August 2017

page(s)

807-817

1 reference

Cholesterol and mortality. 30 years of follow-up from the Framingham study

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.807.34553

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.807.34553

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.807.34553

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.807.34553

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.807.34553

Effects of amiodarone on the circadian pattern of sudden cardiac death (Department of Veterans Affairs Congestive Heart Failure-Survival Trial of Antiarrhythmic Therapy).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.807.34553

Variations in cholesterol management practices of U.S. physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.807.34553

Inadequate management of hyperlipidaemia after coronary bypass surgery shown by medical audit

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.807.34553

A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.807.34553

Management of hypercholesterolemia: practice patterns for primary care providers and cardiologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.807.34553

Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.807.34553

Treatment patterns and distribution of low-density lipoprotein cholesterol levels in treatment-eligible United States adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.807.34553

Impact of evidence-based "clinical judgment" on the number of American adults requiring lipid-lowering therapy based on updated NHANES III data. National Health and Nutrition Examination Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.807.34553

Inadequate treatment with HMG-CoA reductase inhibitors by health care providers

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.807.34553

Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.807.34553

The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.807.34553

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.807.34553

Adults aged 20 and older should have their cholesterol measured

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.807.34553

Cholesterol screening should be targeted

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.807.34553

Management of hyperlipidaemia: guidelines of the British Hyperlipidaemia Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.807.34553

Cholesterol screening in asymptomatic adults, revisited. Part 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.807.34553

Dietary reduction of serum cholesterol concentration: time to think again

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.807.34553

Despite good compliance, very low fat diet alone does not achieve recommended cholesterol goals in outpatients with coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.807.34553

Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.807.34553

The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.807.34553

Population awareness and control of hypertension and hypercholesterolemia. The Atherosclerosis Risk in Communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.807.34553

Cholesterol awareness and treatment in patients with coronary artery disease participating in cardiac rehabilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.807.34553

Current status of cholesterol treatment in the community: The Minnesota heart survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.807.34553

Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP): a randomized trial design of the effect of a community pharmacist intervention program on serum cholesterol risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.807.34553

Achieving National Cholesterol Education Program goals for low-density lipoprotein cholesterol in cardiac patients: importance of diet, exercise, weight control, and drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.9.807.34553

10.1592/PHCO.21.9.807.34553

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference